期刊文献+

AcSDKP对大鼠矽肺纤维化转化生长因子-β1和结缔组织生长因子表达的抑制 被引量:7

Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline mediated by regulation of transforming growth factor beta and connective tissue growth factor expression on rats with silicosis
原文传递
导出
摘要 目的探讨N-乙酰基-丝氨酰-天冬氨酰-赖氨酰-脯氨酸(AcSDKP)对大鼠肺内转化生长因子(TGF)-β1、结缔组织生长因子(CTGF)表达的影响。方法将大鼠随机分为6组,每组10只。对照组大鼠支气管内灌注1.0ml生理盐水,矽肺模型对照1组4周后处死,矽肺模型对照2组8周后处死;矽肺模型组大鼠予SiO:混悬液50mg/ml,矽肺模型1组4周后处死,矽肺模型2组8周后处死;抗纤维化治疗组(治疗组):支气管内灌注SiO:混悬液50mg/ml,4周后给予AcSDKP800μg/(kg·d),至第8周处死;预防治疗组给予AcSDKP800μg/(kg·d)48h后,支气管内灌注SiO:混悬液50mg/ml,8周后处死。HE染色进行形态学观察;采用免疫组织化学法检测TGF—β1与CTGF的蛋白表达;采用实时荧光定量聚合酶链反应(PCR)及反转录-聚合酶链反应(RT—PCR)法检测TGF-β1,与CTGF的mRNA表达。结果治疗组TGF-β1及CTGF蛋白表达分别为0.244±0.016、0.241±0.017,明显低于矽肺模型1组和矽肺模型2组;治疗组TGF-β1mRNA及CTGFmRNA表达水平明显低于矽肺模型1组和矽肺模型2组,差异均有统计学意义(P〈0.05);预防治疗组TGF—β1和CTGF蛋白表达和mRNA表达水平明显低于矽肺模型2组,差异均有统计学意义(P〈0.05)。结论AcSDKP能减轻实验性矽肺纤维化大鼠肺组织中的TGF-β1与CTGF表达水平。 Objective To investigate whether the effect of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) on transforrming growth factor beta (TGF-β1) and connective tissus growth factor (CTGF) was involved in AcSDKP's antifibrotic effect on the rats with silicosis. Methods Rats were divided into 6 groups randomly, 10 rats in each group: Control of silicotic model: 1.0 ml normal sodium and was killed after 4 or 8weeks; Silicotic model 1:50 mg/ml silica suspension and was killed after 4 weeks; Silicotic model 2:50 mg/ml silica suspension and was killed after 8 weeks; Anti-fibrosis treatment of AcSDKP: after each rat was intratracheally instilled with 50 mg/ml silica suspension for 4 weeks, AcSDKP 800 μg/(kg·d) was administered into every rat and rats were killed at the 8 weeks; Preventing fibrosis treatment of AcSDKP: after AcSDKP [800 μg/(kg·d) ] was administered into every rat for 48 hours, each rat was intratracheally instilled with 50 mg/ml silica suspension and rats were killed at the 8 weeks. Lung fibrosis in morphology was observed by HE staining. The expressions of TGF-β1 and CTGF in lung were observed by immunohistochemistry. The mRNA expressions of TGF-β1 and CTGF in lung were observed by real-time PCR. Results In anti-fibrosis treatment of AcSDKP group, protein expression of TGF-β1 and CTGF were (0.244±0.016) and (0.241±0.017)respectively, and significantly lower that those in the silicotic model 1 and 2 groups; mRNA expressions of TGF-β1 and CTGF decreased, mRNA expressions of CTGF were significantly lower that those in the silicotic model 1 and 2 groups(P〈0.05 ) ; In preventing fibrosis treatment of AcSDKP group, protein expression and mRNA expression of TGF-β1 were significantly lower that those in the silicotic model 2 group (P〈0.05). Conclusion AcSDKP can decrease the expressions of TGF-β1 and CTGF in lung tissues of the rats with experimentally induced pulmonary fibrosis.
出处 《中华劳动卫生职业病杂志》 CAS CSCD 北大核心 2009年第7期390-394,共5页 Chinese Journal of Industrial Hygiene and Occupational Diseases
基金 人事部留学人员科技活动资助项目(国人厅发[2006]164号) 河北省自然科学基金资助项目(C2005000807) 唐山市新药基础研究重点实验室资助项目(04362001B-9)
关键词 矽肺 肺纤维化 转化生长因子β 结缔组织生长因子 Silicosis Pulmonary fibrosis Transforming growth factor-beta Connective tissue growth factor
作者简介 通讯作者:杨方,E—mail:fangyang02@sohu.com
  • 相关文献

参考文献8

  • 1Semenzalo G,Adami F,Maschio N,et al.Immune mechanisms in interstitial lung disoaes.Allergy,2000,55:1103-1120.
  • 2Kanasaki K,Koya D,Sugimoto T,et al.N-acetyl-seryl-aspartyl-lysylproline inhibits TGF-β-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells.J Am Soc Nephrol,2003,14:863-872.
  • 3Rhuleb NE,Peng H,Harding P,et al.Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts.Hypertension,2001,37:827-832.
  • 4闫静波,张丽娟,李倩,陈萍,李丹丹,杨方.N-乙酰基-丝氨酰-天门冬酰-赖氨酰-脯氨酸抗大鼠矽肺纤维化的实验研究[J].中华劳动卫生职业病杂志,2008,26(7):401-405. 被引量:23
  • 5Wang D,Carretem OA,Yang XY,et al.N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo.Am J Physiol Heart Circ Physiol,2004,287:H2099-2105.
  • 6Jackson JD,Ozerol E,Yan Y,et al.Activity of acetyl-Ser-Asp-LysPro (AeSDKP) on human hematopoietic progenitor cells in shortterm and long-term bone marrow cultures.J Hematother Stem Cell Res,2000,9:489-96.
  • 7Yang F,Yang XP,Liu YH,et al.Ae-SDKP reverses inflammation and fibrosis in rats with heart failure after myoeardial infarction.Hypertension,2004,43:229-236.
  • 8Monssad EE,Brigstock DR.Connective tissue growth factor:what's in a name? Mol Genet Metab,2000,71:267-292.

二级参考文献14

  • 1杨方,朱曦龄,王丽平,宋旭东,王瑞敏,李治国,罗玲,户万秘,马文东,裴鑫,张丽娟,李琪佳.抗纤维化短肽N-乙酰基-丝氨酰-天门冬酰-赖氨酰-脯氨酸对大鼠心脏成纤维细胞胶原合成与降解的调节作用[J].中华心血管病杂志,2006,34(9):843-846. 被引量:17
  • 2Rimala B,Greenberga AK,Rom WN. Basic pathogenetic mechanisms in silicosis:current understanding. Curr Opin Pulm Med ,2005,11 : 169-173.
  • 3Schuppan D, Koda M,Bauer M,et al. Fibrosis of liver,pancreas and intestine:common mechanism and clear targets? Acta Gastroenterol Belg, 2000,63 : 366-370.
  • 4李才.器官纤维诧基础与临床.北京:人民卫生出版社,2003:207-210.
  • 5Frindel E,Guigon M. Inhibition of CFU entry into cycle by a bone marrow extract. Exp H ematol, 1977,5:74-76.
  • 6Rhaleb NE,Peng H,Harding P,et al. Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts. Hypertension, 2001,37 : 827-832.
  • 7Peng H, Carretero OA, Raij L, et al. Antifibrotic effects of N-acetylseryl-aspartyl-lysyl-proline on the heart and kidney in aldosteronesalt hypertensive rats. Hypertension, 2001,37 : 794-800.
  • 8Yang F,Yang XP,Liu YH,et al. Ae-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction. Hypertension, 2004,43 : 229-236.
  • 9Peng H,Carretero OA,Brigstock DR,et al. Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension. Hypertension, 2003,42:1164-1170.
  • 10Rhaleb NE,Peng H,Yang XP,et al. Long-term effect of N-acetylseryl-aspartyMysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension. Circulation, 2001,103 : 3136-3141.

共引文献22

同被引文献94

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部